The “Vascular Surgery COVID-19 Collaborative” (VASCC)

D’Oria, Mario; Mills, Joseph L.; Cohnert, Tina; Oderich, Gustavo S.; Hultgren, Rebecka; Lepidi, Sandro

doi:10.1016/j.ejvs.2020.07.072

Cited by 20 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Earlier reports have described the local 12 or nationwide 13 effects of COVID-19 and the lockdown in the vascular field. There are currently few available data to analyze how the pandemic has influenced carotid revascularization 3 , 13 , 14 , and large ongoing international studies, such as the COvid-19 Vascular sERvice (COVER) Study and the Vascular Surgery COVID-19 Collaborative (VASCC), are currently working on an assessment of the impact of the COVID-19 pandemic on vascular procedures 15 , 16 . Nevertheless, several authors have emphasized the urgent need to quantify the pandemic’s effects on surgical interventions and the practices of surgical teams 15 , 16 , 17 .…”

Section: Discussionmentioning

confidence: 99%

Impact of the first COVID-19 pandemic peak and lockdown on the interventional management of carotid artery stenosis in France

Crespy

Benzenine

Mariet

et al. 2022

Journal of Vascular Surgery

View full text Add to dashboard Cite

Objective The aim of this study was to evaluate the impact of the COVID-19 pandemic on the trends of carotid revascularization (endarterectomy (CEA), transfemoral stenting (TFCAS)) for symptomatic and asymptomatic carotid stenosis before, during and after the end of the first lockdown in 2020 in France. Methods Nationwide data were provided by the French National Hospital Discharge database ( Programme de Médicalisation des Systèmes d’Information ). We retrospectively analyzed patients admitted for CEA or TFCAS in all French public and private hospitals during a nine-month period (January-September) in 2017, 2018, 2019 and 2020. Procedures were identified using the French Common Classification of Medical Procedures. Stenoses were considered symptomatic in the presence of stroke and/or transient ischemic attack codes (according to the International Classification of Diseases-Tenth Revision) during the stay, and asymptomatic in the absence of these codes. Hospitalization rates in 2020 were compared with the rates in the same period in the three previous years. Results Between January and September 2020, 12 546 patients were hospitalized for carotid artery surgery (CEA and TFCAS) in France. Compared with the three previous years, there was a decline in hospitalization rates for asymptomatic (-68.9%) and symptomatic (-12.6%) CEA procedures in April, starting at the pandemic peak concomitant with the first national lockdown. This decrease was significant for asymptomatic CEA (p<0.001). After the lockdown, while CEA for asymptomatic stenosis returned to usual activity, CEA for symptomatic stenosis presented a significant rebound, up 18.52% in August compared with previous years. Lockdown also had consequences on TFCAS procedures, with fewer interventions for both asymptomatic (-60.53%) and symptomatic stenosis (-16.67%) in April. Conclusions This study demonstrates a severe drop for all interventions during the first peak of the COVID-19 pandemic in France. However, the trends in the post-lockdown period were different for the various procedures. These data can be used to anticipate future decisions and organization for cardiovascular care.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of the first COVID-19 pandemic peak and lockdown on the interventional management of carotid artery stenosis in France

Crespy

Benzenine

Mariet

et al. 2022

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…Reports from Massachusetts observe a decline in procedures between 18 March 2020 and the end of the year, even after resumption of normal services ( 10 ). Initiatives like the Vascular Surgery COVID-19 Collaborative (VASCC) ( 11 ) and the COVID-19 Vascular Service (COVER) study ( 12 ) will hopefully further elucidate the impact of de SARS-CoV-2 pandemic on vascular practices worldwide.…”

Section: Discussionmentioning

confidence: 99%

Treating Peripheral Arterial Occlusive Disease and Acute Limb Ischemia During a COVID-19 Pandemic in 2020

Exelmans

Knaapen

Winter

et al. 2022

Annals of Vascular Surgery

View full text Add to dashboard Cite

Objective For many surgeons the outbreak of SARS-CoV-2 meant a downscaling of surgical interventions. The aim of this study was to investigate the impact of the measures taken on the care for patients with peripheral arterial disease (PAOD) and acute limb ischemia (ALI). Methods A retrospective analysis of the vascular practices of two major teaching hospitals in the Netherlands was performed. All interventions and outpatient visits for PAOD or ALI in 2020 were included. Patients treated in 2018 and 2019 were to serve as a control group. Data were analysed using descriptive statistics. Results In 2020, a total of 1513 procedures were performed for PAOD or ALI. This did not differ significantly from previous years. Overall, Fontaine 2 and 4 were the most frequent indications for intervention. A significant increase in the number of major amputations was observed in 2020 compared to 2018 (p <0.01). This was mainly due to patients suffering from PAOD Fontaine 4. Inversely, a reduction in the number of femoro-popliteal bypasses was observed between 2020 and 2018. The number of outpatient visit due to Fontaine 2 was significantly lower in 2020 compared to 2018. Conclusion The vascular practices of our hospitals were minimally influenced by the measures taken due to the outbreak of SARS-CoV-2. There was an increase in the number of amputation but an enormous surge in patients presenting with critical limb ischemia was not observed.

show abstract

“…The cardiovascular community should further support ongoing efforts to collect data to protect patients from avoidable collateral damage. 33 With growing evidence for an impact of COVID-19 on patients with acute stroke derived from real world data, particular attention should be paid to this vulnerable group. Increased awareness and public recommendations to use emergency services may be reasonable.…”

Section: Discussionmentioning

confidence: 99%

How Does SARS-CoV-2 Infection Affect Survival of Emergency Cardiovascular Patients? A Cohort Study From a German Insurance Claims Database

Behrendt

Seiffert

Gerloff

et al. 2021

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

WHAT THIS PAPER ADDSThis large scale analysis of nationwide and unselected health insurance claims data covering 316 718 hospitalisations for cardiovascular and cerebrovascular emergencies between January 2017 and October 2020 in Germany revealed an association between the COVID-19 pandemic and acute stroke and confirmed SARS-CoV-2 infection (for acute stroke, acute limb ischaemia, transient ischaemic attack) led to increased in hospital mortality in patients admitted with cardiovascular and cerebrovascular emergencies. These striking results add to the extremely limited knowledge base concerning a possible relationship between COVID-19 and stroke. Future studies are necessary to determine underlying causal factors.Objective: A previous study revealed a preliminary trend towards higher in hospital mortality in patients admitted as an emergency with acute stroke during the COVID-19 pandemic in Germany. The current study aimed to further examine the possible impact of a confirmed SARS-CoV-2 infection on in hospital mortality. Methods: This was a retrospective analysis of health insurance claims data from the second largest insurance fund in Germany, BARMER. Patients hospitalised for ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction, acute limb ischaemia (ALI), aortic rupture, acute stroke, or transient ischaemic attack (TIA) between 1 January 2017, and 31 October 2020, were included. Admission rates per 10 000 insured and mortality were compared between March À June 2017 e 2019 (pre-COVID) and March À June 2020 (COVID). Mortality rates were determined by the occurrence of a confirmed SARS-CoV-2 infection. Results: A total of 316 718 hospitalisations were included (48.7% female, mean 72.5 years), and 21 191 (6.7%, 95% CI 6.6% e 6.8%) deaths occurred. In hospital mortality increased during the COVID-19 pandemic when compared with the three previous years for patients with acute stroke from 8.3% (95% CI 8.0 e 8.5) to 9.6% (95% CI 9.1 e 10.2), while no statistically significant changes were observed for STEMI, NSTEMI, ALI, aortic rupture, and TIA. When comparing patients with confirmed SARS-CoV-2 infection (2.4%, 95% CI 2.3 e 2.5) vs. non-infected patients, a higher in hospital mortality was observed for acute stroke (12.4% vs. 9.0%), ALI (14.3% vs. 5.0%), and TIA (2.7% vs. 0.3%), while no statistically significant differences were observed for STEMI, NSTEMI, and aortic rupture. Conclusion: This retrospective analysis of claims data has provided hints of an association between the COVID-19 pandemic and increased in hospital mortality in patients with acute stroke. Furthermore, confirmed SARS-CoV-2 infection was associated with increased mortality in patients with stroke, TIA, and ALI. Future studies are urgently needed to better understand the underlying mechanism and relationship between the new coronavirus and acute stroke.

show abstract

The “Vascular Surgery COVID-19 Collaborative” (VASCC)

Cited by 20 publications

References 5 publications

Impact of the first COVID-19 pandemic peak and lockdown on the interventional management of carotid artery stenosis in France

Impact of the first COVID-19 pandemic peak and lockdown on the interventional management of carotid artery stenosis in France

Treating Peripheral Arterial Occlusive Disease and Acute Limb Ischemia During a COVID-19 Pandemic in 2020

How Does SARS-CoV-2 Infection Affect Survival of Emergency Cardiovascular Patients? A Cohort Study From a German Insurance Claims Database

Contact Info

Product

Resources

About